n-acetylneuraminic acid has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ajmal, MR; Khan, RH; Zaidi, N; Zaidi, SA | 1 |
Wang, L; Yang, C; Zhang, J; Zhang, X | 1 |
Kuiper, M; Mulder, K; van Kamp, GJ; Wolters, EC | 1 |
3 other study(ies) available for n-acetylneuraminic acid and Parkinson Disease
Article | Year |
---|---|
Mechanistic In Vitro Dissection of the Inhibition of Amyloid Fibrillation by
Topics: Amyloid; Amyloidogenic Proteins; Dissection; Humans; N-Acetylneuraminic Acid; Parkinson Disease | 2022 |
High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.
Topics: Aged; Biomarkers; Brain; Chromatography, High Pressure Liquid; Female; Gangliosides; Humans; Lipid Metabolism; Lipids; Male; Mass Spectrometry; Middle Aged; N-Acetylneuraminic Acid; Parkinson Disease; Phospholipid Transfer Proteins; Plasma; ROC Curve | 2017 |
Changed transferrin sialylation in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Parkinson Disease; Sialic Acids; Transferrin | 1995 |